The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved
for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study included about 800 older men with low testosterone and symptoms associated with this condition, like anti aging supplement (tinyurl.com
) sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.
Studies have shown that testosterone deficiency is related to several significant health issues for example metabolic syndrome, obesity, diabetes, and bone fractures Men who meet medical criteria for treatment should receive therapy. In reality, your testosterone levels have probably been slowly declining for quite some time, a decline that usually starts around age 30.
And many girls have a knee jerk feeling that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only does not increase a woman's risk of breast cancer
, it may play a vital role in warding off the disease. Glaser believes this will probably stay the status quo for some time, given the prohibitive cost of running the long term safety studies needed to win FDA approval that is fuller.